When the new GMPs for herbal products were finalized by the Food and Drug Administration (FDA) in June 2007, many breathed a sigh of relief: the FDA was not requiring practitioners who make their own products for their clients to adhere to the new regulations. The FDA did retain the authority, however, to do so in the future. This raises questions for herbalists, like “What would cause the FDA to come knocking" on an herbalist's door or to change their minds and require us to follow the guidelines?There are few better people than Roy Upton to answer these questions or to discuss the ways to ensure that your clients are receiving high-quality herbal medicines.
Registration is open for the second installment in the 2009 AHG TeleSeminar Series. Roy Upton, AHG's Vice-President, will be speaking on "What Do the FDA Good Manufacturing Practices Mean for Herbalists" on May 4 at 7:00 p.m., EST.
Trained in both traditional Western and Chinese herbalism, Roy Upton is a founding and professional member of the American Herbalists Guild. His background includes extensive study with various Native American and non-Native herbalists, ethnobotany of the United States Virgin Islands, and seven years of clinical practice, followed by a three-year clinical internship with Michael Tierra and training at the Shanghai University of Traditional Chinese Medicine, Shanghai, China. He is the executive director and editor of the American Herbal Pharmacopoeia® and is also a member of the Standards Committee of the American Herbal Products Association.
In his "day job," Upton is general manager of Planetary Formulas. He writes extensively and is the author of St. John's Wort and Echinacea, as well as co-author of the Botanical Safety Handbook—a landmark text of herbal safety—and is currently active in the preparation of a new edition.
To register for the AHG TeleSeminar, call the AHG Office at (203) 272-6731 or visit: http://americanherbalistsguild.com/node/132.
No comments:
Post a Comment